ArticleJournal of thoracic disease2026

Liposomal bupivacaine versus ropivacaine thoracic paravertebral block for thoracoscopic atrial septal defect repair: analgesic efficacy and cardiac biomarker outcomes in a single-center, assessor-blinded, randomized trial.

Bingqian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.